Publication

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

ESC Sci Document Grp, 1-May-2018, In : Europace. 20, 5, p. 731-732an 42 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

    Final publisher's version, 4 MB, PDF-document

DOI

  • ESC Sci Document Grp
Original languageEnglish
Pages (from-to)731-732an
Number of pages42
JournalEuropace
Volume20
Issue number5
Publication statusPublished - 1-May-2018

    Keywords

  • Arrhythmias, Antiarrhythmic drugs, Supraventricular arrhythmias, Extrasystoles, Atrial fibrillation, Ventricular tachycardia, Sudden cardiac death, Proarrhythmias, Pre-excitation, Bradycardia, EHRA consensus document, ONSET ATRIAL-FIBRILLATION, TORSADE-DE-POINTES, SUDDEN CARDIAC DEATH, ACUTE MYOCARDIAL-INFARCTION, LONG-QT SYNDROME, RECURRENT VENTRICULAR-TACHYCARDIA, RANDOMIZED CONTROLLED-TRIALS, PLACEBO-CONTROLLED TRIAL, ARRHYTHMIA-INDUCED CARDIOMYOPATHIES, ACC/AHA/ESC 2006 GUIDELINES

View graph of relations

ID: 74540975